Shop

HALOTESTIN- HALO 10MG 25MG 50MG
June 8, 2016
BOLDENONE (EQ 300)
June 8, 2016
Show all

CLOMID 50MG

$45.00

Clomifene or Clomiphene (also known as Clomifert), marketed as Clomid, is a selective estrogen receptor modulator (SERM) that increases production of gonadotropins by inhibiting negative feedback on the hypothalamus. Clomid inhibits estrogen receptors in the hypothalamus, thereby inhibiting negative feedback of estrogen on gonadotropin production. It may also result in direct stimulation of the hypothalamic pituitary adrenal axis. In short, Clomid provides the bodybuilder with a controlled and dependable post cycle treatment specifically in the return of the testicles to normal size and function (it brings your balls back).

Clo50mg has 60 capsules per pouch.

SKU: OR010 Category:
Each capsule contains:  
Clomifene USP 50mg
Excipients QS  
Packing: 60 units in a sealed pouch BP  

Dosage and administration:

Half life 6 days
50 – 300mg per day or as demanded by your PCT requirements

Average Cycle Length: 2-6 weeks

Anabolic #: NA
Androgenic #: NA
Oral Bioavailability: Estimated at 90%

CAS Name: (17b)-17-Hydroxy-17-methylandrosta-1,4-dien-3-one

Synonyms: Clomid, Clomiphene, Androxal, Omifin

Reviews

There are no reviews yet.

Be the first to review “CLOMID 50MG”

Contraindications

Liver disease: Clomid 50mg Tablets (Clomifene Citrate BP) therapy is contraindicated in patients with liver disease or a history of liver dysfunction. Abnormal uterine bleeding: Clomid 50mg Tablets is contraindicated in patients with hormone-dependent tumours or in patients with abnormal uterine bleeding of undetermined origin.

Adverse reactions

Common adverse drug reactions associated with the use of clomifene (?1% of patients) include: vasomotor flushes (or hot flashes ), abdominal discomfort, visual blurring (dose-dependent), and/or reversible ovarian enlargement and cyst formation. Infrequent adverse effects (0.1?1% of patients) include: abnormal uterine bleeding, nausea, and/or vomiting. Rare adverse effects (<0.1% of patients) include: reversible alopecia and/or ovarian hyperstimulation syndrome.[